Sleep Aids - EMEA | Statista Market Forecast

Sleep Aids - EMEA

EMEA

Highlights

Revenue in the Sleep Aids market amounts to US$1.77bn in 2024. The market is expected to grow annually by 1.97% (CAGR 2024-2028).
In global comparison, most revenue is generated United States (US$2bn in 2024).
In relation to total population figures, per person revenues of US$0.72 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureMethodology

The Sleep Aids market in EMEA is experiencing significant growth and development.

Customer preferences: Customers in the EMEA region are increasingly seeking sleep aids to help them overcome sleep disorders and improve the quality of their sleep. This growing demand can be attributed to several factors, including the high-stress levels and busy lifestyles that are prevalent in many countries in the region. Additionally, the aging population in EMEA is also contributing to the increased demand for sleep aids, as older individuals tend to experience more sleep-related issues.

Trends in the market: One of the key trends in the Sleep Aids market in EMEA is the rising popularity of natural and herbal sleep aids. Many customers in the region are becoming more conscious of the potential side effects of pharmaceutical sleep aids and are seeking alternative options. This has led to an increase in the demand for natural sleep aids, such as herbal supplements and essential oils, which are perceived to be safer and have fewer side effects. Another trend in the market is the growing availability of sleep aids through online channels. E-commerce platforms have made it easier for customers to access a wide range of sleep aids, including prescription medications, over-the-counter products, and natural remedies. This convenience factor has contributed to the growth of the market, as customers can now easily purchase sleep aids from the comfort of their own homes.

Local special circumstances: The Sleep Aids market in EMEA is also influenced by local cultural and regulatory factors. In some countries, there may be cultural norms and beliefs that discourage the use of sleep aids, leading to lower demand. Additionally, regulatory frameworks vary across the region, with some countries having stricter regulations on the sale and distribution of sleep aids. These local circumstances can impact the availability and accessibility of sleep aids in different countries within EMEA.

Underlying macroeconomic factors: The development of the Sleep Aids market in EMEA is also influenced by underlying macroeconomic factors. Economic growth and increasing disposable incomes in the region have contributed to the rising demand for sleep aids. As individuals have more financial resources, they are more willing to spend on products that can improve their sleep quality. Additionally, the healthcare infrastructure and access to healthcare services in different countries within EMEA also play a role in the development of the market. Countries with well-developed healthcare systems may have higher levels of awareness and diagnosis of sleep disorders, leading to increased demand for sleep aids. In conclusion, the Sleep Aids market in EMEA is experiencing growth and development due to increasing customer preferences for sleep aids, including natural and herbal options, as well as the growing availability of sleep aids through online channels. Local cultural and regulatory factors, as well as underlying macroeconomic factors, also influence the development of the market in different countries within EMEA.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.